334 related articles for article (PubMed ID: 16749868)
1. Reaction crystallization of pharmaceutical molecular complexes.
Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
3. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
4. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
5. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
Kojima T; Tsutsumi S; Yamamoto K; Ikeda Y; Moriwaki T
Int J Pharm; 2010 Oct; 399(1-2):52-9. PubMed ID: 20696223
[TBL] [Abstract][Full Text] [Related]
6. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy.
Allesø M; Velaga S; Alhalaweh A; Cornett C; Rasmussen MA; van den Berg F; de Diego HL; Rantanen J
Anal Chem; 2008 Oct; 80(20):7755-64. PubMed ID: 18798651
[TBL] [Abstract][Full Text] [Related]
8. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
9. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
[TBL] [Abstract][Full Text] [Related]
10. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
12. Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy.
Tanaka R; Hattori Y; Ashizawa K; Otsuka M
J Pharm Sci; 2019 Oct; 108(10):3201-3208. PubMed ID: 31279736
[TBL] [Abstract][Full Text] [Related]
13. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying.
Patil SP; Modi SR; Bansal AK
Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188
[TBL] [Abstract][Full Text] [Related]
14. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.
Gao Y; Gao J; Liu Z; Kan H; Zu H; Sun W; Zhang J; Qian S
Int J Pharm; 2012 Nov; 438(1-2):327-35. PubMed ID: 22989978
[TBL] [Abstract][Full Text] [Related]
15. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid.
Aher S; Dhumal R; Mahadik K; Paradkar A; York P
Eur J Pharm Sci; 2010 Dec; 41(5):597-602. PubMed ID: 20801215
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
Soares FL; Carneiro RL
J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
[TBL] [Abstract][Full Text] [Related]
19. Monitoring ibuprofen-nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool.
Kelly AL; Gough T; Dhumal RS; Halsey SA; Paradkar A
Int J Pharm; 2012 Apr; 426(1-2):15-20. PubMed ID: 22274588
[TBL] [Abstract][Full Text] [Related]
20. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
